Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 1497 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| A ... | 24 | 15 | 8 | 16 | 10 | 29 | 16 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 537 |